News & Views: Tag: Porterhouse Insights

  At Porterhouse Insights, we help pharmaceutical and healthcare companies understand the changes in behaviour needed to make better healthcare choices. To promote a change in a certain behaviour, we must first successfully analyse and understand the underlying dimensions that contribute to the behaviour itself. This is not a simple task, and it remains an …

Continue reading “Understanding behaviour change: A Porterhouse Insights specialism”

Read more

  Porterhouse is delighted to announce two well-deserved promotions within the group’s growing research, insights and evidence consultancy. Firstly, we congratulate Melissa Goulding who has been promoted to Senior Research Executive. Melissa joined the growing Porterhouse Insights team in December 2019, with a BSc in Psychology with Neuroscience and a MSc in Cognitive Neuroscience. Since …

Continue reading “Celebrating a double promotion at Porterhouse Insights”

Read more

  Porterhouse Medical Group is delighted to welcome David Eatwell, who joins the team at Porterhouse Insights as Director. David, an experienced and innovative pharma insight professional, will bolster the expertise and capabilities in insight generation and strategy development. David is joining from Cello Health Insight, having previously worked within Consulting at McCann Health (formerly …

Continue reading “Porterhouse Insights expands its senior team following a year of significant growth”

Read more

  To mark the 3rd anniversary of the launch of Porterhouse Insights, Research Executive, Melissa Goulding reflects on her first year working in healthcare insights and how the irregularity of human behaviour makes for a complex patient journey. Before joining Porterhouse, my experience studying neuroscience depicted the patient journey as a cold, static diagram, painting …

Continue reading “The patient journey: A long and winding road”

Read more

Porterhouse Medical Group, specialists in medical communications and insights research, is joining imc group with the support of Waterland Private Equity. Porterhouse’s award-winning team will further imc’s ambition to become the leading, independent provider of global strategic healthcare communications and consulting services to the pharmaceutical and biotech industries. The collaborative fusion between Porterhouse Medical Group …

Continue reading “Award-winning agency Porterhouse Medical Group joins imc group with Waterland Private Equity’s support”

Read more

After another exciting year, Fabrice Allum, Managing Director at Porterhouse Insights, reflects on the benefits of cross-functional working for our pharmaceutical clients.

Read more

Porterhouse Medical Group is celebrating another successful year of providing powerful insight-led solutions to its global clients.

Read more

Fabrice Allum, MD of Porterhouse Insights, looks at behaviour change, and the value of measuring the real-world impact of medical communication and education programmes on behaviour.

Read more

Strategic scientific and medical communications agency, Porterhouse Medical Group, is celebrating the first birthday of Porterhouse Insights, its global research, insight and evidence consultancy.

Read more

Fabrice Allum, managing director of Porterhouse Insights, looks at behaviour change and introduces the Porterhouse BPS.

Read more

Patient experiences are diverse and dynamic. Mapping patient journeys enables us to unlock salient insights and redesign care pathways.

Read more

In late 1846, a dentist from New England, William TG Morton, is attributed to have performed a dental extraction using diethyl ether as a general anaesthetic. While there was much subsequent debate around who pioneered the birth of modern anaesthesia, what is undeniable is the speed with which the practice spread among the medical profession and the impact it had on medicine.1

Read more